1.
Iannazzo S, Pradelli L. Solifenacin in overactive bladder syndrome: pharmacoeconomic analysis. Farmeconomia. Health Economics and Therapeutic Pathways. 2008;9(1):5-14. https://doi.org/10.7175/fe.v9i1.210